GT Biopharma Inc reports results for the quarter ended in September - Earnings Summary

GT Biopharma

11/11/2021 07:10

* GT Biopharma Inc  GTBP.OQ  reported a quarterly adjusted loss
of 19 cents​​ per share for the quarter ended in September. The
mean expectation of three analysts for the quarter was for a
loss of 21 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* GT Biopharma Inc's reported EPS for the quarter was a loss
of 17 cents​.
* The mean earnings estimate of analysts had risen by
about 25.9% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* GT Biopharma Inc shares had fallen by 23.0% this quarter and
lost 28.0% so far this year.
* The company reported a quarterly loss of $5.45 million.
* Wall Street's median 12-month price target for GT Biopharma
Inc is $25.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 07:10 a.m.
 ​All figures in US dollars unless otherwise stated